CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Innovent licenses IBI355 rights to Spero for up to $1.1bn

PartnershipIBI355Positive
AI Analysis

Summary

Innovent has licensed the rights to IBI355 to Spero Therapeutics in a deal with a potential value of up to $1.1 billion. The licensing agreement represents a significant partnership between the two companies.

Importance:7/10
Sentiment:
0.60
licensingpartnershipIBI355deal
Related Companies

Read the original article

Published by yahoo_finance on July 15, 2026 10:01 AM

Read Original